Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4a
|
ENSMUSG00000017950.10 | hepatic nuclear factor 4, alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_163549290_163549771 | Hnf4a | 553 | 0.677069 | 0.84 | 2.7e-17 | Click! |
chr2_163547257_163548345 | Hnf4a | 613 | 0.633847 | 0.84 | 7.8e-17 | Click! |
chr2_163507247_163507946 | Hnf4a | 788 | 0.492923 | 0.81 | 3.3e-15 | Click! |
chr2_163506859_163507228 | Hnf4a | 235 | 0.877386 | 0.80 | 1.4e-14 | Click! |
chr2_163548522_163549154 | Hnf4a | 1245 | 0.354202 | 0.80 | 2.4e-14 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_98446534_98448432 | 11.33 |
Grb7 |
growth factor receptor bound protein 7 |
415 |
0.68 |
chr3_89136417_89137539 | 9.95 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr5_114970896_114971201 | 9.34 |
Hnf1a |
HNF1 homeobox A |
19 |
0.93 |
chr7_141338447_141340687 | 8.16 |
Eps8l2 |
EPS8-like 2 |
561 |
0.53 |
chr19_7294483_7295524 | 8.09 |
Mark2 |
MAP/microtubule affinity regulating kinase 2 |
444 |
0.7 |
chr14_69500320_69500976 | 8.02 |
Gm37094 |
predicted gene, 37094 |
258 |
0.81 |
chr14_69282071_69282727 | 8.01 |
Gm20236 |
predicted gene, 20236 |
259 |
0.8 |
chr6_86078066_86079298 | 7.94 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr1_173331444_173331908 | 7.41 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
1826 |
0.27 |
chr17_49429375_49429751 | 7.24 |
Gm20540 |
predicted gene 20540 |
323 |
0.83 |
chr19_24553917_24554867 | 7.13 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
1397 |
0.38 |
chr2_144230243_144231103 | 6.96 |
4930444E06Rik |
RIKEN cDNA 4930444E06 gene |
12568 |
0.11 |
chr18_54424022_54424266 | 6.92 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
1849 |
0.43 |
chr4_150002224_150002760 | 6.75 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
638 |
0.66 |
chr12_84150828_84152588 | 6.51 |
Pnma1 |
paraneoplastic antigen MA1 |
3219 |
0.13 |
chr9_62857494_62859103 | 6.50 |
Calml4 |
calmodulin-like 4 |
164 |
0.92 |
chr11_49245181_49246325 | 6.48 |
Mgat1 |
mannoside acetylglucosaminyltransferase 1 |
522 |
0.68 |
chr2_84940292_84940460 | 6.46 |
Slc43a3 |
solute carrier family 43, member 3 |
3486 |
0.16 |
chr5_64861805_64862132 | 6.46 |
Klf3 |
Kruppel-like factor 3 (basic) |
35159 |
0.11 |
chr5_66081275_66082011 | 6.41 |
Rbm47 |
RNA binding motif protein 47 |
347 |
0.81 |
chr6_87776091_87777171 | 6.30 |
Gm43904 |
predicted gene, 43904 |
488 |
0.55 |
chr7_109602204_109602761 | 6.27 |
Denn2b |
DENN domain containing 2B |
183 |
0.94 |
chr10_80856664_80858456 | 6.25 |
Sppl2b |
signal peptide peptidase like 2B |
439 |
0.61 |
chr4_132973841_132975368 | 6.14 |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
502 |
0.76 |
chr4_87803942_87804192 | 6.02 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
2227 |
0.44 |
chr11_100931288_100932301 | 6.00 |
Stat3 |
signal transducer and activator of transcription 3 |
7586 |
0.15 |
chr3_115758693_115759280 | 5.97 |
Gm9889 |
predicted gene 9889 |
43836 |
0.13 |
chr19_5724785_5726881 | 5.86 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr11_83849571_83850989 | 5.82 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr8_123819889_123820495 | 5.75 |
Rab4a |
RAB4A, member RAS oncogene family |
7137 |
0.1 |
chr17_25222989_25223237 | 5.75 |
Unkl |
unkempt family like zinc finger |
334 |
0.75 |
chr7_99594627_99596228 | 5.70 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr9_107975554_107976970 | 5.69 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr4_118526960_118527939 | 5.61 |
2610528J11Rik |
RIKEN cDNA 2610528J11 gene |
206 |
0.89 |
chr11_76854511_76855173 | 5.48 |
Cpd |
carboxypeptidase D |
7824 |
0.2 |
chr1_131274859_131275440 | 5.42 |
Ikbke |
inhibitor of kappaB kinase epsilon |
1564 |
0.27 |
chr11_109470335_109470717 | 5.41 |
Slc16a6 |
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
2162 |
0.18 |
chr5_114965020_114965640 | 5.32 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
3454 |
0.1 |
chr1_82815577_82816643 | 5.24 |
Gm28942 |
predicted gene 28942 |
3725 |
0.11 |
chrX_48424911_48425565 | 5.23 |
Elf4 |
E74-like factor 4 (ets domain transcription factor) |
28931 |
0.15 |
chr8_60973849_60974245 | 5.16 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
9192 |
0.15 |
chrX_48146526_48147857 | 5.13 |
Sash3 |
SAM and SH3 domain containing 3 |
755 |
0.65 |
chr8_119438798_119439203 | 5.11 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
1811 |
0.28 |
chr17_34881444_34882339 | 5.09 |
C2 |
complement component 2 (within H-2S) |
76 |
0.57 |
chr7_143473761_143474585 | 5.06 |
Slc22a18 |
solute carrier family 22 (organic cation transporter), member 18 |
368 |
0.79 |
chr12_51851512_51851798 | 5.05 |
Gm19309 |
predicted gene, 19309 |
11034 |
0.19 |
chr4_148670937_148671621 | 5.01 |
Gm572 |
predicted gene 572 |
27962 |
0.12 |
chr8_13200696_13201435 | 5.01 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
245 |
0.65 |
chr16_34807078_34808442 | 4.99 |
Mylk |
myosin, light polypeptide kinase |
22839 |
0.23 |
chr18_35847749_35850271 | 4.92 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr11_48869797_48870455 | 4.91 |
Irgm1 |
immunity-related GTPase family M member 1 |
1248 |
0.29 |
chr1_90969196_90969800 | 4.90 |
Rab17 |
RAB17, member RAS oncogene family |
50 |
0.96 |
chr14_19708369_19709189 | 4.86 |
Gm49341 |
predicted gene, 49341 |
11570 |
0.13 |
chr2_69380501_69380861 | 4.83 |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
236 |
0.94 |
chr11_58199579_58200256 | 4.76 |
Irgm2 |
immunity-related GTPase family M member 2 |
299 |
0.49 |
chr6_115591641_115592523 | 4.76 |
Mkrn2os |
makorin, ring finger protein 2, opposite strand |
467 |
0.71 |
chr18_74780353_74780504 | 4.73 |
Acaa2 |
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) |
1231 |
0.32 |
chr6_51129516_51130052 | 4.72 |
Mir148a |
microRNA 148a |
140126 |
0.04 |
chr11_20634522_20634924 | 4.70 |
Sertad2 |
SERTA domain containing 2 |
2744 |
0.3 |
chr10_60346425_60348008 | 4.60 |
Vsir |
V-set immunoregulatory receptor |
204 |
0.94 |
chr12_76535555_76536098 | 4.58 |
Plekhg3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
2206 |
0.21 |
chr5_105731410_105732771 | 4.57 |
Lrrc8d |
leucine rich repeat containing 8D |
27 |
0.98 |
chr7_84687806_84688726 | 4.55 |
2610206C17Rik |
RIKEN cDNA 2610206C17 gene |
1374 |
0.34 |
chr7_127121221_127122317 | 4.54 |
Qprt |
quinolinate phosphoribosyltransferase |
249 |
0.81 |
chr19_39739090_39739575 | 4.52 |
Cyp2c68 |
cytochrome P450, family 2, subfamily c, polypeptide 68 |
1722 |
0.45 |
chr7_19082814_19086200 | 4.51 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr3_122731783_122732467 | 4.51 |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
1903 |
0.33 |
chr11_103102696_103105788 | 4.50 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr5_4004947_4005528 | 4.46 |
Wdr46-ps |
Wdr46 retrotransposed pseudogene |
16231 |
0.17 |
chr11_46698808_46698979 | 4.37 |
Timd2 |
T cell immunoglobulin and mucin domain containing 2 |
69 |
0.97 |
chr6_136940269_136941762 | 4.36 |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
488 |
0.73 |
chr12_17505773_17506236 | 4.35 |
Odc1 |
ornithine decarboxylase, structural 1 |
38790 |
0.11 |
chr9_48334625_48335180 | 4.31 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
5932 |
0.22 |
chr2_173047915_173048486 | 4.26 |
Gm14453 |
predicted gene 14453 |
13620 |
0.13 |
chr1_171225202_171226411 | 4.25 |
Apoa2 |
apolipoprotein A-II |
715 |
0.4 |
chr4_45403235_45403849 | 4.24 |
Slc25a51 |
solute carrier family 25, member 51 |
1324 |
0.36 |
chr7_100465236_100467118 | 4.15 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr14_66279066_66281333 | 4.15 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr11_77892631_77894065 | 4.14 |
Pipox |
pipecolic acid oxidase |
748 |
0.58 |
chr4_154294238_154294673 | 4.13 |
Arhgef16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
5437 |
0.18 |
chr19_43606378_43607779 | 4.12 |
Gm20467 |
predicted gene 20467 |
3547 |
0.14 |
chr16_90739931_90740383 | 4.11 |
Mrap |
melanocortin 2 receptor accessory protein |
1833 |
0.28 |
chr14_55757552_55758723 | 4.09 |
Cideb |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
242 |
0.79 |
chr6_101271529_101272523 | 4.08 |
9530086O07Rik |
RIKEN cDNA 9530086O07 gene |
16484 |
0.18 |
chr11_75463013_75463425 | 4.04 |
Mir22 |
microRNA 22 |
497 |
0.52 |
chr18_69925227_69926323 | 4.04 |
Ccdc68 |
coiled-coil domain containing 68 |
199 |
0.94 |
chr9_21015148_21016366 | 4.02 |
Icam1 |
intercellular adhesion molecule 1 |
228 |
0.81 |
chr3_135718664_135719150 | 4.00 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
27360 |
0.17 |
chr11_54026747_54027441 | 3.99 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
858 |
0.54 |
chr18_20666097_20666725 | 3.94 |
Ttr |
transthyretin |
1131 |
0.34 |
chr15_99098752_99100136 | 3.94 |
Dnajc22 |
DnaJ heat shock protein family (Hsp40) member C22 |
32 |
0.95 |
chr12_17506418_17506872 | 3.93 |
Odc1 |
ornithine decarboxylase, structural 1 |
38149 |
0.11 |
chr11_84825293_84825636 | 3.92 |
Dhrs11 |
dehydrogenase/reductase (SDR family) member 11 |
3500 |
0.14 |
chr11_97443224_97443536 | 3.92 |
Arhgap23 |
Rho GTPase activating protein 23 |
6780 |
0.17 |
chr9_80335849_80336097 | 3.90 |
Myo6 |
myosin VI |
29059 |
0.2 |
chr7_35121962_35122959 | 3.87 |
Gm45091 |
predicted gene 45091 |
2855 |
0.13 |
chr5_17828701_17829205 | 3.85 |
Cd36 |
CD36 molecule |
6743 |
0.32 |
chr8_120335264_120336251 | 3.84 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
107301 |
0.05 |
chr17_45591436_45592600 | 3.84 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
244 |
0.84 |
chr2_32721862_32722483 | 3.84 |
Sh2d3c |
SH2 domain containing 3C |
1117 |
0.24 |
chr8_11279195_11280201 | 3.76 |
Col4a1 |
collagen, type IV, alpha 1 |
42 |
0.97 |
chrX_48143101_48144179 | 3.76 |
Sash3 |
SAM and SH3 domain containing 3 |
2796 |
0.26 |
chr5_150598920_150599238 | 3.75 |
Gm43598 |
predicted gene 43598 |
461 |
0.63 |
chr3_90669217_90670598 | 3.75 |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
596 |
0.55 |
chr8_83216489_83216744 | 3.75 |
Tbc1d9 |
TBC1 domain family, member 9 |
42643 |
0.11 |
chr8_84701273_84703379 | 3.73 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr15_10358528_10358782 | 3.72 |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
76 |
0.97 |
chr12_103827485_103827986 | 3.71 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
2638 |
0.15 |
chrX_75128292_75128967 | 3.68 |
Mpp1 |
membrane protein, palmitoylated |
2215 |
0.17 |
chr11_115899671_115901427 | 3.67 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr4_151719200_151719482 | 3.67 |
Camta1 |
calmodulin binding transcription activator 1 |
142309 |
0.04 |
chr15_78245409_78246081 | 3.65 |
Ncf4 |
neutrophil cytosolic factor 4 |
901 |
0.49 |
chr17_28007198_28009699 | 3.64 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr17_34862282_34862545 | 3.61 |
Cfb |
complement factor B |
101 |
0.87 |
chr2_157456825_157458020 | 3.60 |
Src |
Rous sarcoma oncogene |
337 |
0.88 |
chr1_138174613_138175183 | 3.59 |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
291 |
0.87 |
chr6_99265299_99266669 | 3.58 |
Foxp1 |
forkhead box P1 |
531 |
0.86 |
chr5_53469318_53470522 | 3.55 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
3768 |
0.25 |
chr8_68119212_68120289 | 3.53 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
1563 |
0.51 |
chr8_117701899_117703135 | 3.53 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
430 |
0.77 |
chr5_139737935_139738668 | 3.50 |
Micall2 |
MICAL-like 2 |
1965 |
0.25 |
chr6_55336550_55338274 | 3.50 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr1_171441584_171442042 | 3.50 |
F11r |
F11 receptor |
4234 |
0.11 |
chr19_55285309_55285619 | 3.48 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
1130 |
0.48 |
chr9_107604198_107605624 | 3.47 |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
358 |
0.63 |
chr5_35739030_35739562 | 3.47 |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
691 |
0.66 |
chr17_57233273_57233586 | 3.46 |
C3 |
complement component 3 |
5293 |
0.12 |
chr11_116571734_116571976 | 3.43 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
9592 |
0.1 |
chr6_38920967_38921907 | 3.41 |
Tbxas1 |
thromboxane A synthase 1, platelet |
2413 |
0.31 |
chr2_155612818_155614078 | 3.40 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
2236 |
0.14 |
chr7_132494201_132494423 | 3.38 |
Gm4587 |
predicted gene 4587 |
10654 |
0.18 |
chr8_94172106_94173724 | 3.37 |
Mt2 |
metallothionein 2 |
55 |
0.87 |
chr8_123978308_123979538 | 3.36 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr6_34155216_34155451 | 3.36 |
Gm13856 |
predicted gene 13856 |
3404 |
0.22 |
chr10_42270697_42271036 | 3.36 |
Foxo3 |
forkhead box O3 |
5830 |
0.27 |
chr7_115844339_115844623 | 3.35 |
Sox6 |
SRY (sex determining region Y)-box 6 |
1624 |
0.52 |
chr11_4987942_4988093 | 3.33 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
1083 |
0.42 |
chr18_32551644_32552119 | 3.32 |
Gypc |
glycophorin C |
8099 |
0.21 |
chr7_25249035_25250700 | 3.31 |
Erf |
Ets2 repressor factor |
863 |
0.36 |
chr15_97342251_97342686 | 3.30 |
Pced1b |
PC-esterase domain containing 1B |
18734 |
0.22 |
chr11_98580331_98580961 | 3.30 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
6722 |
0.11 |
chr15_76118017_76119354 | 3.30 |
Eppk1 |
epiplakin 1 |
1510 |
0.2 |
chrX_12001809_12002609 | 3.30 |
Gm14512 |
predicted gene 14512 |
17741 |
0.23 |
chr12_103863075_103863579 | 3.28 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
224 |
0.87 |
chr17_88626308_88627392 | 3.27 |
Ston1 |
stonin 1 |
17 |
0.97 |
chr14_101839786_101841002 | 3.27 |
Lmo7 |
LIM domain only 7 |
97 |
0.98 |
chr4_41096220_41096829 | 3.26 |
Aqp3 |
aquaporin 3 |
1659 |
0.24 |
chr10_80017523_80018162 | 3.26 |
Arhgap45 |
Rho GTPase activating protein 45 |
926 |
0.32 |
chr1_167375050_167375216 | 3.18 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
10967 |
0.13 |
chr10_81128980_81129986 | 3.18 |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
868 |
0.33 |
chrX_150552023_150552275 | 3.18 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
1888 |
0.27 |
chr11_84827522_84827949 | 3.17 |
Dhrs11 |
dehydrogenase/reductase (SDR family) member 11 |
1229 |
0.28 |
chr4_133372816_133373783 | 3.17 |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
2655 |
0.19 |
chr19_43886463_43887251 | 3.16 |
Dnmbp |
dynamin binding protein |
3834 |
0.17 |
chr11_115177591_115178410 | 3.15 |
Nat9 |
N-acetyltransferase 9 (GCN5-related, putative) |
9081 |
0.11 |
chr6_3988317_3988783 | 3.15 |
Tfpi2 |
tissue factor pathway inhibitor 2 |
308 |
0.88 |
chr2_4562127_4563316 | 3.13 |
Frmd4a |
FERM domain containing 4A |
2946 |
0.28 |
chr3_146407041_146407816 | 3.11 |
Ssx2ip |
synovial sarcoma, X 2 interacting protein |
2450 |
0.2 |
chr10_21377273_21377859 | 3.11 |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
219 |
0.91 |
chr3_122107431_122107792 | 3.11 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
12429 |
0.17 |
chr2_148043571_148045987 | 3.10 |
Foxa2 |
forkhead box A2 |
685 |
0.65 |
chr4_63153559_63154085 | 3.08 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
351 |
0.86 |
chr8_13060543_13060844 | 3.07 |
Proz |
protein Z, vitamin K-dependent plasma glycoprotein |
221 |
0.86 |
chr2_122148370_122148749 | 3.07 |
B2m |
beta-2 microglobulin |
873 |
0.46 |
chr13_23560818_23560969 | 3.06 |
H3c6 |
H3 clustered histone 6 |
1476 |
0.12 |
chr2_164436239_164437366 | 3.05 |
Sdc4 |
syndecan 4 |
6384 |
0.09 |
chr7_46029818_46030744 | 3.05 |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
21 |
0.96 |
chr15_99890238_99891314 | 3.04 |
Gm18890 |
predicted gene, 18890 |
7136 |
0.08 |
chr12_103773135_103773583 | 3.04 |
Serpina1d |
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
233 |
0.87 |
chr2_101827517_101827720 | 3.01 |
Prr5l |
proline rich 5 like |
11362 |
0.22 |
chr10_25535843_25536173 | 3.01 |
Smlr1 |
small leucine-rich protein 1 |
134 |
0.78 |
chr5_123131617_123134965 | 3.00 |
Rhof |
ras homolog family member F (in filopodia) |
599 |
0.36 |
chr14_54408224_54410842 | 3.00 |
Slc7a7 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
73 |
0.94 |
chr7_120979495_120980366 | 2.99 |
Cdr2 |
cerebellar degeneration-related 2 |
1860 |
0.19 |
chr3_104632268_104633005 | 2.98 |
Gm43582 |
predicted gene 43582 |
2021 |
0.18 |
chr19_43887649_43888282 | 2.98 |
Dnmbp |
dynamin binding protein |
2726 |
0.21 |
chr10_28271889_28272164 | 2.96 |
Gm22370 |
predicted gene, 22370 |
57905 |
0.16 |
chr16_93364963_93365114 | 2.93 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
291 |
0.88 |
chr5_137569837_137570642 | 2.93 |
Tfr2 |
transferrin receptor 2 |
370 |
0.67 |
chr14_55712926_55713937 | 2.92 |
Tgm1 |
transglutaminase 1, K polypeptide |
61 |
0.91 |
chr7_119280701_119281119 | 2.92 |
Gm4083 |
predicted gene 4083 |
20797 |
0.18 |
chr4_120668815_120668969 | 2.91 |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
2320 |
0.24 |
chr10_81139604_81140150 | 2.90 |
Zbtb7a |
zinc finger and BTB domain containing 7a |
1924 |
0.14 |
chr9_107590316_107591253 | 2.89 |
Ifrd2 |
interferon-related developmental regulator 2 |
323 |
0.64 |
chr4_106581338_106582731 | 2.88 |
Gm12744 |
predicted gene 12744 |
7074 |
0.12 |
chr4_133007332_133008511 | 2.88 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
3339 |
0.22 |
chr19_5050501_5051991 | 2.88 |
Rin1 |
Ras and Rab interactor 1 |
413 |
0.61 |
chr19_5722830_5723507 | 2.87 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
3102 |
0.08 |
chr4_33245981_33246490 | 2.87 |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
1340 |
0.4 |
chr9_21167780_21169096 | 2.87 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
2724 |
0.15 |
chr3_107877327_107877896 | 2.87 |
Eps8l3 |
EPS8-like 3 |
349 |
0.71 |
chr19_6400799_6402159 | 2.87 |
Rasgrp2 |
RAS, guanyl releasing protein 2 |
216 |
0.85 |
chr17_27559013_27559762 | 2.86 |
Hmga1 |
high mobility group AT-hook 1 |
2692 |
0.11 |
chr12_103956429_103956881 | 2.84 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
243 |
0.87 |
chr4_141558806_141560164 | 2.83 |
B330016D10Rik |
RIKEN cDNA B330016D10 gene |
13296 |
0.12 |
chr2_104123741_104123892 | 2.83 |
A930018P22Rik |
RIKEN cDNA A930018P22 gene |
1047 |
0.43 |
chr11_21549928_21550553 | 2.83 |
Mdh1 |
malate dehydrogenase 1, NAD (soluble) |
9489 |
0.14 |
chr13_43193557_43193708 | 2.82 |
Tbc1d7 |
TBC1 domain family, member 7 |
22131 |
0.19 |
chr11_90686857_90688331 | 2.82 |
Tom1l1 |
target of myb1-like 1 (chicken) |
6 |
0.98 |
chr2_143889620_143889950 | 2.82 |
Gm11686 |
predicted gene 11686 |
8608 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.7 | 5.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.6 | 4.9 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
1.5 | 9.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.5 | 4.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.5 | 6.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.5 | 10.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.5 | 5.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.4 | 4.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.4 | 5.6 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.3 | 4.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.3 | 6.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.3 | 3.8 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.2 | 3.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.2 | 3.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 3.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 5.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 3.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.1 | 4.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.1 | 13.9 | GO:0070293 | renal absorption(GO:0070293) |
1.0 | 1.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.0 | 3.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 3.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.0 | 3.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.0 | 4.0 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.0 | 2.0 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.0 | 2.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.0 | 5.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.9 | 2.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.9 | 2.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.9 | 2.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.8 | 3.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 2.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.8 | 2.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.8 | 3.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.8 | 2.3 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 2.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 2.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.7 | 4.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.7 | 3.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 2.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.7 | 0.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.7 | 2.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 7.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 2.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.7 | 2.8 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.7 | 1.4 | GO:0002434 | immune complex clearance(GO:0002434) |
0.7 | 6.1 | GO:0097286 | iron ion import(GO:0097286) |
0.7 | 2.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 2.0 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 2.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.6 | 5.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 1.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 1.9 | GO:1901656 | glycoside transport(GO:1901656) |
0.6 | 3.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.6 | 1.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.6 | 1.8 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.6 | 3.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 2.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 3.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 1.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.6 | 0.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.6 | 1.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.6 | 1.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 0.6 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.5 | 2.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 1.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 1.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 2.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.5 | 1.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.5 | 3.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 2.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 2.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 0.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 1.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.0 | GO:0045472 | response to ether(GO:0045472) |
0.5 | 1.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.5 | 3.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 3.4 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.5 | 1.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.5 | 2.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 3.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.5 | 0.5 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.5 | 0.9 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 1.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 2.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 4.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 1.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 0.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 1.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.5 | 0.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 2.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 1.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 1.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 1.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 1.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.4 | 6.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 1.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 1.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 1.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.4 | 1.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.7 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 1.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 1.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 2.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 3.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 4.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 2.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 2.4 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.4 | 1.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.4 | 5.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 0.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.4 | 4.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.4 | 1.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 0.4 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.4 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 6.1 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.4 | 5.4 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.4 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.4 | 1.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.7 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.3 | 1.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 2.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 1.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 1.0 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 1.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 1.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 1.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 1.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 1.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 1.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 1.0 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.3 | 0.6 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.3 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 2.8 | GO:0019627 | urea metabolic process(GO:0019627) |
0.3 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 0.6 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.3 | 1.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 0.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 2.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 3.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 0.9 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.3 | 0.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 1.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.5 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.9 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 1.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 2.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 2.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.3 | GO:0098754 | detoxification(GO:0098754) |
0.3 | 0.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.3 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 1.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 0.8 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 1.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.3 | 3.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.8 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 1.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 2.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 2.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 2.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 1.9 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 0.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.8 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 2.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 1.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 1.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.9 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.3 | 0.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 0.8 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 1.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 0.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 6.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.8 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.3 | 0.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 0.8 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 0.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 0.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 0.8 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 0.5 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 1.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.5 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.2 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 0.5 | GO:0070662 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 1.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.2 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 1.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 2.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 1.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 1.4 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 3.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 1.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 1.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 1.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.9 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.7 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.2 | 0.2 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 4.6 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 1.3 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.2 | 1.7 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 1.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.4 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.2 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.8 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 4.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 1.0 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.2 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 1.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 0.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 1.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.6 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 4.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.6 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 2.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 3.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 0.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.6 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 0.2 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.2 | 0.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.2 | 1.5 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 1.3 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.2 | 1.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.2 | 0.4 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.2 | 0.2 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.2 | 1.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 1.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 0.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 2.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.5 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.7 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 1.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 1.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 2.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 2.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.2 | 0.7 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.2 | 0.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.8 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.2 | 0.5 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.2 | 2.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 2.3 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 5.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.6 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 1.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 1.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.2 | 0.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.3 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.2 | 0.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 2.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.6 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.2 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.9 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.8 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 1.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.6 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 1.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 2.9 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 3.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 1.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 1.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 1.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.8 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.3 | GO:0036166 | phenotypic switching(GO:0036166) |
0.1 | 1.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.6 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.1 | 0.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.9 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.5 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.9 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 1.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 2.1 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.1 | 0.4 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.1 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.1 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 1.0 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 1.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 1.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 1.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.2 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.1 | 0.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.5 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.4 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 1.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.1 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.6 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.3 | GO:0046416 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 1.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 4.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 1.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 1.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.3 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.5 | GO:1903912 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.3 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.1 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 1.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 1.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.2 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 1.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 1.1 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 2.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 1.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 12.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 2.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.3 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.9 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 2.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.1 | 0.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 1.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.2 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.1 | 2.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.1 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.1 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.4 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.5 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.3 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.1 | 0.3 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.4 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 1.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.1 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.1 | GO:0001798 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 2.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.8 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 2.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.7 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 1.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.2 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.2 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.1 | GO:0002524 | hypersensitivity(GO:0002524) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 1.0 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.1 | 0.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.0 | 0.1 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.5 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 1.7 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.0 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 1.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.4 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.0 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.1 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.0 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.0 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.0 | GO:0018904 | ether metabolic process(GO:0018904) |
0.0 | 0.2 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.5 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.0 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.0 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.0 | 0.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 1.1 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 1.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 2.1 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.3 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.0 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.6 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.0 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 1.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.0 | 0.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.1 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.0 | 0.0 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.5 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.3 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.0 | 0.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.0 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.0 | 0.0 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0009112 | pyrimidine nucleobase metabolic process(GO:0006206) nucleobase metabolic process(GO:0009112) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.2 | GO:0033617 | respiratory chain complex IV assembly(GO:0008535) mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.0 | 0.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.0 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.1 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.0 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 1.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0090220 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.3 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.0 | 0.0 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.0 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.0 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.2 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.3 | 3.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.2 | 5.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 7.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.8 | 3.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.8 | 1.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.7 | 5.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.7 | 4.2 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.7 | 3.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 2.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.6 | 2.9 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 2.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.5 | 2.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 9.1 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 2.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 2.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 3.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 12.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 1.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 3.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 0.6 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 1.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 0.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 2.3 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 0.8 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 1.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 2.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 14.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 2.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 4.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.7 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.0 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 1.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 5.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 2.3 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 2.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 5.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.5 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 4.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.5 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.2 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 3.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 2.5 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 2.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 2.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 5.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 5.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.7 | GO:0005818 | aster(GO:0005818) |
0.1 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 2.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 3.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 2.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 8.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 8.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 6.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 20.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 6.1 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 2.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 6.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.6 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 1.0 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.8 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 5.9 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 1.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 4.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 118.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 4.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 2.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 1.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 2.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 1.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 2.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 6.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.2 | GO:0071010 | prespliceosome(GO:0071010) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 4.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.3 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.6 | GO:0098687 | chromosomal region(GO:0098687) |
0.0 | 0.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.6 | 4.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.4 | 5.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.3 | 6.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.3 | 3.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.3 | 7.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.2 | 6.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 3.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.1 | 3.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 3.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.0 | 3.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.9 | 2.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.9 | 2.8 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 2.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.9 | 5.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 2.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.8 | 3.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 3.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 2.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.7 | 2.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.7 | 2.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.6 | 2.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.6 | 3.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.6 | 1.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.6 | 2.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 1.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 1.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 2.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 4.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 6.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 1.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 1.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 4.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 2.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 1.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 3.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 2.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 9.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 6.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 2.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 1.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 0.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 3.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 4.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 1.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 2.0 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 2.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 1.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 1.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 10.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.4 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 2.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 0.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.4 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 2.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.4 | 1.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 1.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 6.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 1.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 2.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 3.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 6.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 3.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 0.9 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 2.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 1.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 0.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 1.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.9 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.3 | 0.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 0.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 0.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 1.8 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 1.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.7 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 1.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 2.0 | GO:0042469 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 3.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 1.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 2.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.7 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 2.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 1.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 2.5 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 2.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 2.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 7.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 5.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 3.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 7.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.8 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 5.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.6 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.2 | 2.3 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 2.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 2.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 2.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 3.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 2.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 0.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 2.0 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.2 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.1 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 17.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 4.4 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 2.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 2.2 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.9 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 2.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 1.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 1.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 2.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.7 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 3.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 6.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 1.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.5 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 6.0 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.6 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 2.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.8 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.1 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 2.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 2.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 1.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 3.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 2.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 1.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.7 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 2.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.7 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 2.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 4.1 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 14.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.7 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 3.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.1 | 1.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.7 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 6.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.1 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.5 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 4.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 2.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 4.1 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 3.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 7.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.2 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0034813 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.4 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 1.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.3 | GO:0034783 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 2.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0018499 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.8 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 1.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.6 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 1.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 2.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 8.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 4.2 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.0 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.5 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 3.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.4 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.5 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 36.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 3.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 2.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 8.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 7.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 8.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 3.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 10.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 2.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 3.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 12.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 1.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 4.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 7.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 9.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 5.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 4.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 3.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 5.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 3.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 3.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 3.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.0 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 2.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 9.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 9.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 20.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.7 | 6.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 7.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.6 | 9.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 5.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 5.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 3.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 6.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 7.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 1.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 3.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 5.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 3.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 4.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 3.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 10.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 3.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 4.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 0.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 3.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 3.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 10.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 3.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 2.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 3.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 0.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 6.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 0.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 0.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 5.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 0.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 2.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 5.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 4.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 2.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 3.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 2.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 3.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 2.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 8.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 7.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 1.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 2.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 2.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 4.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 2.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |